{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:41:23Z","timestamp":1777502483861,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Department of Biotechnology (DBT), Govt. of India","award":["MAP\/2015\/58"],"award-info":[{"award-number":["MAP\/2015\/58"]}]},{"name":"Indo-Brazil Grant","award":["DBT\/IC-2\/Indo-Brazil\/2016-19\/01"],"award-info":[{"award-number":["DBT\/IC-2\/Indo-Brazil\/2016-19\/01"]}]},{"DOI":"10.13039\/501100001409","name":"DST","doi-asserted-by":"publisher","award":["ECR\/2016\/000007"],"award-info":[{"award-number":["ECR\/2016\/000007"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.intimp.2019.03.035","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T07:48:10Z","timestamp":1553845690000},"page":"301-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms"],"prefix":"10.1016","volume":"71","author":[{"given":"Shruthi","family":"Sunkari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sowjanya","family":"Thatikonda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Pooladanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerabhadra Swamy","family":"Challa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.03.035_bb0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/10715762.2016.1162301","article-title":"Oxidative stress in psoriasis and potential therapeutic use of antioxidants","volume":"50","author":"Lin","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.intimp.2019.03.035_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12291-010-0043-9","article-title":"Role of oxidative stress in various stages of psoriasis","volume":"25","author":"Kadam","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.intimp.2019.03.035_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28488-6","article-title":"Naturally derived Heme-Oxygenase 1 inducers attenuate inflammatory responses in human dendritic cells and T cells: relevance for psoriasis treatment","volume":"8","author":"Campbell","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.03.035_bb0020","first-page":"CR30","article-title":"Oxidant-antioxidant balance in patients with psoriasis","volume":"13","author":"Wo\u017aniak","year":"2007","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.intimp.2019.03.035_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2278-0","article-title":"Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database","volume":"17","author":"Feldman","year":"2017","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.intimp.2019.03.035_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12895-018-0074-0","article-title":"Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database","volume":"18","author":"Sruamsiri","year":"2018","journal-title":"BMC Dermatol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/bjhs.bjhs_11_17","article-title":"Biologicals in the treatment of psoriasis: the Indian perspective","author":"Janagond","year":"2017","journal-title":"BLDE Univ. J. Health Sci."},{"key":"10.1016\/j.intimp.2019.03.035_bb0040","first-page":"153","article-title":"Tacrolimus for the management of psoriasis: clinical utility and place in therapy","volume":"6","author":"Malecic","year":"2016","journal-title":"Psoriasis Auckl. NZ."},{"key":"10.1016\/j.intimp.2019.03.035_bb0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/CLEP.S146442","article-title":"A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)","volume":"10","author":"Castellsague","year":"2018","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0050","first-page":"61","article-title":"The role of nitric oxide in the pathogenesis and severity of psoriasis","author":"Matoshvili","year":"2014","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.intimp.2019.03.035_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI12153","article-title":"A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis","volume":"108","author":"Haase","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2019.03.035_bb0060","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/jid.2013.182","article-title":"NF-\u03baB and STAT3 inhibition as a therapeutic strategy in psoriasis: in vitro and in vivo effects of BTH","volume":"133","author":"Andr\u00e9s","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.intimp.2019.03.035_bb0070","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"3","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2019.03.035_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0923-1811(02)00064-6","article-title":"Extracellular regulated kinase and c-Jun N-terminal kinase are activated in psoriatic involved epidermis","volume":"30","author":"Takahashi","year":"2002","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2019.03.035_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/0970-2113.63603","article-title":"Ambroxol - resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases","volume":"27","author":"Gupta","year":"2010","journal-title":"Lung India Off. Organ Indian Chest Soc."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2019.03.035_bb0085","first-page":"42","article-title":"Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo","volume":"51","author":"Olivieri","year":"1987","journal-title":"Respir. Int. Rev. Thorac. Dis."},{"key":"10.1016\/j.intimp.2019.03.035_bb0090","doi-asserted-by":"crossref","unstructured":"M. Plomer, J. de Zeeuw, [More than expectorant: new scientific data on ambroxol in the context of the treatment of bronchopulmonary diseases], MMW Fortschr. Med. 159 (2017) 22\u201333.","DOI":"10.1007\/s15006-017-9805-0"},{"key":"10.1016\/j.intimp.2019.03.035_bb0095","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2169\/internalmedicine.50.5407","article-title":"Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats","volume":"50","author":"Zhi","year":"2011","journal-title":"Intern. Med. Tokyo Jpn."},{"key":"10.1016\/j.intimp.2019.03.035_bb0100","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00134-003-2001-y","article-title":"Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide","volume":"30","author":"Su","year":"2004","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2019.03.035_bb0105","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10238-006-0099-2","article-title":"Ambroxol for the prevention of acute upper respiratory disease","volume":"6","author":"Nobata","year":"2006","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.intimp.2019.03.035_bb0115","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2019.03.035_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0970-2113.125899","article-title":"Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: clinical trials are the need of the hour","volume":"31","author":"Gupta","year":"2014","journal-title":"Lung India Off. Organ Indian Chest Soc."},{"key":"10.1016\/j.intimp.2019.03.035_bb0125","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1039\/C8NJ03248C","article-title":"Synthesis and in vitro cytotoxicity evaluation of \u03b2-carboline-linked 2,4-thiazolidinedione hybrids: potential DNA intercalation and apoptosis-inducing studies","volume":"42","author":"Tokala","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.intimp.2019.03.035_bb0130","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0135","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.nano.2017.06.009","article-title":"Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis","volume":"13","author":"Jain","year":"2017","journal-title":"Nanomedicine Nanotechnol. Biol. Med."},{"issue":"32","key":"10.1016\/j.intimp.2019.03.035_bb0140","first-page":"38","article-title":"Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway","volume":"32","author":"Di","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0145","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.fsi.2012.06.024","article-title":"A manganese superoxide dismutase (MnSOD) from Ruditapes philippinarum: comparative structural- and expressional-analysis with copper\/zinc superoxide dismutase (Cu\/ZnSOD) and biochemical analysis of its antioxidant activities","volume":"33","author":"Umasuthan","year":"2012","journal-title":"Fish Shellfish Immunol"},{"key":"10.1016\/j.intimp.2019.03.035_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1165\/rcmb.2013-0195OC","article-title":"MicroRNA-326 regulates profibrotic functions of transforming growth factor-\u03b2 in pulmonary fibrosis","volume":"50","author":"Das","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0155","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2019.03.035_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00248","article-title":"An adaptogen: withaferin A ameliorates in vitro and in vivo pulmonary fibrosis by modulating the interplay of fibrotic, matricelluar proteins, and cytokines","volume":"9","author":"Bale","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0165","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tiv.2018.05.010","article-title":"Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer","volume":"51","author":"Pooladanda","year":"2018","journal-title":"Toxicol. Vitro Int."},{"key":"10.1016\/j.intimp.2019.03.035_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41419-018-1247-9","article-title":"Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-\u03b1 mediated NF-\u03baB and HDAC-3 nuclear translocation","volume":"10","author":"Pooladanda","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2019.03.035_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.39","article-title":"Betulin exhibits anti-inflammatory activity in LPS-stimulated macrophages and endotoxin-shocked mice through an AMPK\/AKT\/Nrf2-dependent mechanism","volume":"8","author":"Ci","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2019.03.035_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2405291","article-title":"Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis","volume":"2017","author":"Tan","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2019.03.035_bb0185","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2016.02.030","article-title":"Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1\/2 signaling pathway","volume":"775","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1293\/tox.2016-0050","article-title":"Suppressive effects of the expectorant drug ambroxol hydrochloride on quartz-induced lung inflammation in F344 rats","volume":"30","author":"Kanie","year":"2017","journal-title":"J. Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.intimp.2019.03.035_bb0195","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(98)90506-6","article-title":"Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy","volume":"92","author":"Gillissen","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.intimp.2019.03.035_bb0200","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000445645","article-title":"Terminalia chebulanin attenuates psoriatic skin lesion via regulation of heme oxygenase-1","volume":"39","author":"An","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2019.03.035_bb0205","doi-asserted-by":"crossref","first-page":"71.8","DOI":"10.4049\/jimmunol.188.Supp.71.8","article-title":"Role of regulatory T cells and TGF-\u03b2 in an experimental model of psoriasis in mice (71.8)","volume":"188","author":"Zanvit","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2019.03.035_bb0215","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2019.03.035_bb0220","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/molecules23040717","article-title":"Heterophyllin B ameliorates lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the PI3K\/Akt pathways","volume":"23","author":"Yang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2019.03.035_bb0225","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1271\/bbb.67.1916","article-title":"Suppressive effects of genistein on oxidative stress and NFkappaB activation in RAW 264.7 macrophages","volume":"67","author":"Choi","year":"2003","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2019.03.035_bb0230","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-\u03b1 and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2019.03.035_bb0235","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00403-012-1272-y","article-title":"Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress","volume":"304","author":"Baek","year":"2012","journal-title":"Arch. Dermatol. Res."},{"issue":"2006","key":"10.1016\/j.intimp.2019.03.035_bb0240","first-page":"1431","article-title":"Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2","volume":"176","author":"Johansen","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2019.03.035_bb0245","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: an essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2019.03.035_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051243","article-title":"A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors","volume":"8","author":"Peroval","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.03.035_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065355","article-title":"Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol","volume":"8","author":"Bognar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2019.03.035_bb0260","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.jid.5700777","article-title":"Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions","volume":"127","author":"Redondo","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.03.035_bb0265","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/emm.2017.81","article-title":"Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice","volume":"49","author":"Jeon","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2019.03.035_bb0270","doi-asserted-by":"crossref","first-page":"e67078","DOI":"10.1371\/journal.pone.0067078","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:12:47Z","timestamp":1761585167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918309056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":54,"alternative-id":["S1567576918309056"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.03.035","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of ambroxol in psoriasis like skin inflammation: Exploration of possible mechanisms","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.03.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}